Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 196 participants.
Also called NCT01657461
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 196 participants
- Registry
-
NCT01657461
-
- Other papers using this trial's data
- Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)
- Efficacy of Stent-Retriever Thrombectomy in Magnetic Resonance Imaging Versus Computed Tomographic Perfusion-Selected Patients in SWIFT PRIME Trial (Solitaire FR With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)
- Predictive Value of RAPID Assessed Perfusion Thresholds on Final Infarct Volume in SWIFT PRIME (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment)
- Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke
- Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME
- Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01657461. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-01 (actual). Results posted on 2017-05-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial
- Acronym
- SWIFT PRIME
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
- Intervention (Device)
- Solitaire revascularization device
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
Record details
- Record id
cardio:ct-nct01657461- Content hash
0036b2d9265f6f0ac080b4e41c2ced2939a7bca43f1054e12c0d10a9c719e6fd